Abstract
Hepatobiliary agents with Tc99m are tracers of bile flow, of bile storage in the gall bladder, of hepatocyte metabolism, of gastrointestinal propagation or of reflux from duodenum (or ileum) into the stomach; the latter objectives require rapid arrival of a sufficient amount of tracer in the duodenum (fig.1). A relatively large number of Tc99m labeled hepatobiliary tracers have been described in the scientific literature:
-
Derivatives of N- (Phenylcarbamoylmethyl) iminodiacetic acid (1,2)
-
Dihydro-thioctic acid (DHT) (3)
-
Mercaptoisobutyric acid (4)
-
Pyridoxylidene Glutamate (PyG) (5)
-
Pyridoxal Leucine (OyL) (5,6,7,8)
-
Pyridoxalphenylalanin (9,10)
-
8-Hydroxy-quinolin-7-carboxylate (11)
-
D-Penicillamine (12)
-
Tetracycline (13)
-
Toluidine blue (14)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Burns D, Marzilli L, Sowa D, Bauern D, Wagner Jr H, Relationship between molecular structure and biliary excretion of Technetium-99m Hida and Hida analogs (abstract) J. nucl. Med. 18: 624, 1977.
Wistow BW, Subramanian G, Van Heertum RL, Henderson RW, Gagne GM, Hall RC, McAfee JG, An evaluation of 99mTc-labeled hepatobiliary agents. J. nucl. Med. 18: 455, 1977.
Tonkin AK, DeLand FH, Dihydrothioctic acid: a new polygonal cell imaging agent (abstract) J. nucl. Med. 15: 539, 1974.
Lin TH, Kentigan A, Winchell HS, A 59mTc-labeled replacement for 1311-Rose Bengal in liver and biliary tract studies. J. nucl. Med. 15: 613, 1974.
Baker RJ, Bellen JC, Ronai PM, 99mTc-pyridoxylideneglutamate: a new rapid cholescintigraphic agent. J. nucl. Med. 15: 476, 1974.
Baker RJ, Bellen JC, Ronai PM, Technetium pyridoxilideneglutamate: a new hepatobiliary radiopharmaceutical. I. Experimental aspects. J. nucl. Med. 16: 720, 1975.
Ronai PM, Baker RJ, Bellen JC, Technetium 99m pyridoxylidene glutamate, a new hepatobiliary radiopharmaceutical. II. Clinical aspects. J. nucl. Med. 16: 728, 1975.
Poulose KP, Eckelman WC, Reba RC, Evaluation of 99mTc-pyridoxylideneglutamate for the differential diagnosis of jaundice. Clin. Nucl. Med. 1: 70, 1976.
Fotopoulos A, Evaluation of 99mTc-pyridoxalphenylalanine as a hepatobiliary imaging agent. Part. F. Experimental studies. J. nucl. Med. 18: 1189, 1977.
Papadimitriou A, Fotopoulos C, Koutoulidis C, Chiotelis E, Tountas C, Evaluation of Tc99m pyridoxal phenyldanine as a hepatobiliary agent. Port 2. Clinical tests. J. nucl. Med. 18: 1194, 1977.
Fritzberg AR, Lyster DM, Dolphin DH, 99mTc-Bioquin-7 CA, a potential new hepatobiliary scanning agent. J. nucl. Med. 17: 907, 1976.
Krishnamurthy GT, Tubis M, Endow JS, Blahol WS, Tc-pencillamine, a new radio-pharmaceutical for cholescintigraphy (abstract) J. nucl. Med. 13: 447, 1972.
Fliegel G, Pewanjee MK, Holman BL, Davis MA, Treves S, 99m.Tc tetracycline as a kidney and gall-bladder imaging agent. Radiology 110: 407, 1974.
Yeh SH, Delahay JE, Kriss JP, Tc 99m labelled toluidine blue 0 for liver scintillography. Int. J. Appl. Radiat. 19: 885, 1968.
Loberg MD, Fields AT, Chemical Structure of Technetium-99-labeled N-(e, 6dimethylphenylcarbamoylmethyliminodiacetic acid (Tc-HIDA). J. of Appl. Rad. ‘sot. 29: 167, 1978.
ICRP,23, Report of the task group on reference man. Oxford, Pergamon press 1974.
Hendriksen HJ, Winkler K, Hepatobiliäre Funktionsszintigraphie mit IDAderivaten. In: Proceedings of the symposium of North-Rhine Westphalian Society of Nuclear Medicine, April 1978, Bonn. Biersack HJ, Mahlstedt J (eds), Darmstadt, G-I-T/E Giebler, 1978.
Ryan J, Cooper M, Loberg M, Harvey E, Sikorski S, Technetium-99m-labeled N-(2,6 dimethylpheylcarbamoylmethyl) iminodiacetic acid (Tc-99m HIDA: a new radiopharmaceutical for hepatobiliary imaging studies. J. nucl. Med. 18: 995, 1977.
Passath A, Leb G, Ergebnisse der Leberszintigraphie mit einer neuen Kolloidsubstanz (99mTc-Sn-Antipyrin RD 77 1268) im Vergleich mit 99mTc-Sn-Phytat, 18, 79. Nukl. Med. 18: 79, 1979.
Fueger GF, Unpublished data, 1977.
Fueger GF, Unpublished data, 1978.
Dudzak R, Kletter K, Angelberger P, Frischauf H, Comparison of two different biliary agents in healthy subjects and in patients with liver diseases. Eur. J. Nucl. Med. 4: 365, 1979.
Dudzak R, Angelberger P, Kletter K, Wagner-Löffler M, Ferencsi P, Frischauf H, Comparison of 99mTc-Diethylida with 99mTc-Parabutylida in jaundiced patients. In:IAEA, SM 247–153, Proceedings of the IAEA symposium on medical radionuclide imaging, Heidelberg, September 1980.
Bengoa J, Ritschard J, Donath A, Szintigraphie hepatobiliäre: rest fonctionnel. Schweiz. med. Wschr. 108: 1896, 1978.
Joseph K, Mahlstedt J, Welcke U, Pries HH, Hepatobiliäre Funktionsszintigraphie (HBFS) mit Hepatobida. NucComp. 1: 20, 1977.
Reichelt HG, Nuklearmedizinische Leber-und Gallenwegsdiagnostik mit dem hepatotropen, cholophilen Radiopharmakon 99mTc-Diäthyl-IDA (EHIDA). NucComp. 9: 18, 1978.
Hernandez M, Rosenthall L, A cross-over study of the kinetics of 99mTclabeled Diethyl-and Diisopropyl-IDA. Clin. Nucl. Med. 5: 352, 1980.
Tongendorff J, Raithel E, Böll U, Grunst J, Trumm F, Scherer R, Die Wertigkeit der hepatobiliären Funktionsszintigraphie mit 99mTc-Diäthyl-IDA. Nucl. Med. 17: 30, 1978.
Passath A, Leb G, Möglichkeiten in der Differentialdiagnose zwischen Parenchym-und Verschlussikterus mit 99mTc-Hida durch Auswertung von Funtionsparametern. Nukl. Med. 19: 127, 1980.
Vetter H, Studies of hepatic circulation, function and morphology. In: Radioisotopes in medical diagnosis, Belcher EH, Vetter H (eds), London, Butterworth, 1971.
Pors Nielsen S, Trap-Jensen J, Lindenberg J, Lykkegard Nielsen M, Hepatobiliary scintigraphy and hepatography with Tc-99m diethyl-acetanilido-iminodiacetate in obstructive jaundice. J. nucl. Med. 19: 452, 1978.
Cox PH, Tjen HSLM, Van der Pompe WB, The clinical value of 99mTc-labelled Diethyl-acetanilido-imino-diacetate complex for dynamic studies of hepatobiliary function. NucComp. 9: 67, 1978.
Biersack JJ, Breuel HP, Thelen M, Winkler C, Beurteilungskriterien der hepatobiliären Funktionsszintigraphie mit 99m-Tc-markiertem Diäthyl-IDA. Fortschr. Röntgenstr. 130: 689, 1979.
Kroiss A, Peschl L, Kogelbauer G, Stellamor K, Neumayr A, Hepatobiliäre Diagnostik mit 99mTc-hepatobida. Leber, Magen, Darm 9: 107, 1979.
Fueger GF, Dittrich G, Diethyl, Trimethyl and p-butyl-derivatives of 99m-Tc hepato-imino-diacetic acid in 5 volonteers and 5 patients with hepatobiliary disease. In: Progress in Radiopharmacology, Vol. I. Cox PH (ed), Amsterdam, Elsevier/North-Holland Biomedical Press, 1979.
Fueger GF, Unpublished data, 1980.
Cox PH, Unpublished data, personal communication, 1980.
Reichelt HG, Langenberg G, Löhlein D, Hepato-biliäre Sequenzszintigraphie in prä-und postoperativer Oberbauchdiagnostik. Chirurg 48: 583, 1977.
Hernandez M, Rosenthal] L, A cross-over study comparing the kinetics of 99mTc-labeled Diisopropyl and P-Butyl IDA analogs in patients. Clin. Nucl. Med. 5: 159, 1980.
Pauwels S, Steels M, Piret L, Beckers C, Clinical evaluation of Tc-99mDiethyl-IDA in hepatobiliary disorders. Nucl. Med. 19: 783, 1978.
Biersack JJ, Breuel HP, Thelen M, Winkler C, Beurteilungskriterien der hepatobiliären Funktionsszintigraphie mit 99mTc-markiertem Diäthyl-IDA. Fortschr. Röntgenstr. 130: 689, 1979.
Tjen HSLM, Cholescintigraphy Ph.D. Thesis, University of Utrecht, The Netherlands (in English ), 1979.
Matolo NM, Stadalnik RC, Wolfman EF, Hepatobiliary scanning using 99mTcPyridoxylidenglutamate. Amer. J. Surg. 133: 116, 1977.
Eikman EA, Cameron JL, Colman M, Radioactive tracer techniques in the diagnosis of acute cholestitis. J. nucl. Med. 14: 393, 1973.
Lubin E, Rachima M, Oren V, Weininger J, Trumper J, Korenitzky I, Rechnic Y, Tc99m Pyridoxylidene Glutamate in jaundiced patients. J. nucl. Med. 19: 24, 1978.
Stöffler G, Holzer H, Chahbazi H, Fueger GF. In: Hepatobiliäre Funktionsszintigraphie mit IDA-Derivaten. Proceedings of the symposium of North-Rhine Westphalian Society of Nuclear Medicine, April 1978, Bonn. Biersack HJ, Mahlstedt J (eds), Darmstadt, G-I-T/E Giebler, 1978.
Welcke U, Hepatobiliäre Funktionsszintigraphie mit IDA-Derivaten. Proceedings of the symposium of North-Rhine Westphalian Society of Nuclear Medicine, April 1978, Bonn, Biersack HJ, Mahlstedt J (eds), Darmstadt, G-I-T/E Giebler, 1978.
Klingensmith WC, Fritzberg AR, Koep LJ, Comparison of Tc-99m Diethyl-iminodiacetic acid and 1–131 Rose Bengal for Hepatobiliary Studies in Liver-transplant patients: concise communication. J. nucl. Med. 20: 314, 1979.
Vanek KN, Brookeman VA, Methodology of absorbed dose determinations for a new hepatobiliary imaging agent (99mTc-DHTA). In: Radiopharmaceutical dosimetry symposium, Cloutier RJ, Coffey JL, Snyder WS, Watson EE (eds), Publication (FDA) Washington, 1976.
Spencer RP, Hosian F, Spitznagle LA, Kinetics and dosimetry of radiopharmaceuticals utilized in evaluating liver, gall-bladder and spleen. In: Radio-pharmaceutical dosimetry symposium, Cloutier RJ, Coffey WS, Snyder WS, Watson EE (eds), Publication (FDA) Washington, 1976.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Martinus Nijhoff Publishers, The Hague
About this chapter
Cite this chapter
Fueger, G.F. (1981). The Biokinetics of Tc99m Labeled Hepatobiliary Agents in Humans. In: Cox, P.H. (eds) Cholescintigraphy. Developments in Nuclear Medicine, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8325-0_6
Download citation
DOI: https://doi.org/10.1007/978-94-009-8325-0_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8327-4
Online ISBN: 978-94-009-8325-0
eBook Packages: Springer Book Archive